Share This

PR Newswire Asia's news > Infectious Disease Control

 < Previous page   |   Detail   |   Print 
     
Seegene and UK Health Security Agency convene a summit to collectively realize "a World Free from All Diseases"
2024-04-08T    Biotechnology   Computer/Electronics   Health Care/Hospital   Infectious Disease Control 
Recbio And Rongsheng Biotech Signed a Strategic Cooperation Agreement On The New Adjuvant Vaccine Project
2024-03-27T    Biotechnology   Health Care/Hospital   Infectious Disease Control   Medical/Pharmaceuticals 
CGTN: China advances battle against tuberculosis
2024-03-25T    Computer/Electronics   Health Care/Hospital   Infectious Disease Control   Multimedia/Online/Internet 
New PeerLINC Knowledge Hub will Leverage Local Expertise and Experience to Accelerate New, More Effective TB Cures Around the World
2024-03-25T    Health Care/Hospital   Infectious Disease Control   Medical/Pharmaceuticals 
Australian Government Grants TB Alliance an Award to Help Bolster Clinical Research and Improve Access to New Treatments for Drug-Resistant TB
2024-03-25T    Health Care/Hospital   Infectious Disease Control   Medical/Pharmaceuticals 
SK bioscience Exports Influenza Vaccine to Thailand, Entering Southern Hemisphere Market
2024-03-21T    Biotechnology   Health Care/Hospital   Infectious Disease Control   Medical/Pharmaceuticals 
Bill & Melinda Gates Medical Research Institute Initiates Phase 3 Clinical Trial of Tuberculosis Vaccine Candidate
2024-03-19T    Health Care/Hospital   Infectious Disease Control   Medical/Pharmaceuticals 
Seegene and Springer Nature Announce Awardees for the Open Innovation Program
2024-03-15T    Biotechnology   Health Care/Hospital   Infectious Disease Control   Medical/Pharmaceuticals 
Hybribio Calls for Raising International HPV Awareness
2024-03-04T    Biotechnology   Education   Health Care/Hospital   Infectious Disease Control 
 < Previous page 

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2024 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.